Suchergebnisse - "CYP3A4 protein, human"

PubPharm (4.358)

1

Induction of human hepatic cytochrome P-450 3A4 expression by antifungal succinate dehydrogenase inhibitors

enthalten in: Ecotoxicology and environmental safety | 2024

von Kerhoas, M. | Carteret, J. | Huchet, L. | +4

2

Unraveling the Ligand-Binding Sites of CYP3A4 by Molecular Dynamics Simulations with Solvent Probes

enthalten in: Journal of chemical information and modeling | 2024

von Feng, Y. | Gong, C. | Zhu, J. | +3

3

Physiologically Based Pharmacokinetic Modeling for Maribavir to Inform Dosing in Drug-Drug Interaction Scenarios with CYP3A4 Inducers and Inhibitors

enthalten in: Journal of clinical pharmacology | 2024

von Chen, G. | Sun, K. | Michon, I. | +5

4

Midostaurin drug interaction profile : a comprehensive assessment of CYP3A, CYP2B6, and CYP2C8 drug substrates, and oral contraceptives in healthy participants

enthalten in: Cancer chemotherapy and pharmacology | 2024

von Sechaud, R. | Gu, H. | Rahmanzadeh, G. | +5

ErratumIn: Cancer Chemother Pharmacol. 2024 Mar 5;:. - PMID 38438807

5

Association of CYP3A4-392A/G, CYP3A5-6986A/G, and ABCB1-3435C/T Polymorphisms with Tacrolimus Dose, Serum Concentration, and Biochemical Parameters in Mexican Patients with Kidney Transplant

enthalten in: Genes | 2024

von Alatorre-Moreno, E. | Saldaña-Cruz, A. | Pérez-Guerrero, E. | +10

6

Assessment of the CYP3A4 Induction Potential by Carbamazepine : Insights from Two Clinical DDI Studies and PBPK Modeling

enthalten in: Clinical pharmacology and therapeutics | 2024

von Kanefendt, F. | Dallmann, A. | Chen, H. | +5

7

Understanding CYP3A4 and P-gp mediated drug-drug interactions through PBPK modeling - Case example of pralsetinib

enthalten in: CPT: pharmacometrics & systems pharmacology | 2024

von Bowman, C. | Dolton, M. | Ma, F. | +5

8

Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug-Drug Interaction of Avacopan in 2 Open-Label Studies in Healthy Participants

enthalten in: Clinical pharmacology in drug development | 2024

von Miao, S. | Bekker, P. | Armas, D. | +4

9

CYP2C8 rs11572080 and CYP3A4 rs2740574 risk genotypes in paclitaxel-treated premenopausal breast cancer patients

enthalten in: Scientific reports | 2024

von Attia, H. | Kamel, M. | Ayoub, D. | +7

10

Time Course of the Interaction Between Oral Short-Term Ritonavir Therapy with Three Factor Xa Inhibitors and the Activity of CYP2D6, CYP2C19, and CYP3A4 in Healthy Volunteers

enthalten in: Clinical pharmacokinetics | 2024

von Rohr, B. | Krohmer, E. | Foerster, K. | +5

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[436]